This FDA response is utter B.S. At a minimum, why did they not ask for the QT data 6 months ago with their first response letter? Bydureon is a great drug, without question. It is expected to be used by millions of people, probably for years at a time (so the need for caution) but this seems over the top to me.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.